Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial

Fig. 2

Comparison of pathologic regression between the Socazolimab + TP and Placebo + TP groups (TP: nab-paclitaxel/cisplatin). The upper plot shows the clinicopathological information of each patient. The lower plot shows the pathological regression of the neoadjuvant treatment. Different colors represent different groups of this study

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us